Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 76 results for "glenmark pharmaceuticals"

Results #39;positive#39; for nasal spray 3rd phase trials: Glenmark
Money Control

Results #39;positive#39; for nasal spray 3rd phase trials: Gle...

The results for GSP 301, a fixed-dose combination of mometasone furoate 25 mcg and olopatadine hydrochloride 665 mcg are from a recently completed phase III trial assessing its efficacy and safety versus mometasone, olopatadine or placebo, it said in a BSE ... Money Control, 8 hours ago

13 images for glenmark pharmaceuticals

Money Control, 1 day ago, 1 month ago
Forbes India, 1 month ago, 2 months ago, 2 months ago
Hindu Business Line, 2 months ago
Pharmacy Times, 2 months ago
Pharmaceutical, 3 months ago
Financial Express, 3 months ago, 4 months ago
Money Control

Glenmark Pharmaceuticals receives final approval for Clobetasol Propionate Ointment

 Business Standard1 week ago Glenmark gets USFDA nod for skin ointment  Business Standard1 week ago Glenmark Pharma receives ANDA approval for Clobetasol Propionate Ointment  Money Control1 week ago Glenmark gets tentative nod from USFDA for Fingolimod capsules  DNA1 week ago

Global Financial Markets Remain Cautious

Posted by Equitymaster Most of the global financial markets ended the week on a negative note. Major global markets were cautious over the week over concerns of the Trump administration's ability to push out reforms. US markets snapped their bull run and ...
 Equitymaster.com5 days ago Global Markets Cheer Softer US Fed Reserve Tone  Equitymaster.com1 week ago

Indian pharma exits the trauma room

India's generic drugmaking industry is getting wheeled out of intensive care. But is it really going home? The US Food and Drug Administration this week lifted the import ban on a factory that Mumbai-based Sun Pharmaceutical Industries inherited as part of ...
 The Financial Chronicle1 week ago
Money Control

Glenmark ties up with Evestra to develop contraceptive

The companies will file for product approval in FY19
 Business Standard4 weeks ago Glenmark, Evestra enter pact for generic contraceptive product  Money Control4 weeks ago Glenmark partners Evestra to market contraceptive product in US  Business Standard4 weeks ago Glenmark Pharma and Evestra announce partnership agreement for generic NuvaRing  Money Control4 weeks ago
Money Control

Glenmark's Ankleshwar plant gets EIR report from USFDA

Drug firm Glenmark has received establishment inspection report (EIR) from the US health regulator on closure of inspection of its Ankleshwar plant in Gujarat, the company said today.
 DNA2 weeks ago Glenmark rises 4% on receipt of inspection report from US FDA  Money Control2 weeks ago Glenmark#39;s Ankleshwar plant gets EIR report from USFDA  Money Control2 weeks ago Pharma major Glenmark's Ankleshwar plant gets EIR report from USFDA  Business Standard2 weeks ago
Money Control

USFDA clears Glenmark's investigational new drug application

Drug major Glenmark today said theUS health regulator has cleared its investigational new drug(IND) application to begin a phase two study of GSP 304 to beused for treatment of a respiratory disease.
 Money Control3 weeks ago Glenmark Pharma up 1% on US FDA nod to drug's first phase  Money Control3 weeks ago Glenmark's blood pressure drug gets US FDA nod; shares up 1%  Money Control2 months ago Sanofi sues Glenmark, Torrent over sclerosis drug  Business Standard2 months ago
Forbes India

Glenmark Q3 FY17 net rises by 143%

Robust operating performance in the US business helps Glenmark post stellar earnings in an otherwise forgettable quarter for Indian pharma By Aveek Datta Forbes India Staff Published: Feb 2, 2017 Full Bio Image: Vikas Khot Mumbai-based generic drug maker ...
 Forbes India1 month ago Glenmark Pharma soars above 5% taking cues from its Q3 results  India Infoline1 month ago Glenmark Q3 net soars 143% to Rs 477 cr aided by US generic biz  Money Control1 month ago Glenmark Q3 net up over two-fold to Rs 477 cr  DNA1 month ago

Glenmark Pharma gets earnings boost

The shares of Glenmark Pharmaceuticals surged about 7 per cent in early trades on Friday on the back of strong third-quarter (Q3) earnings. The stock recorded a high of 970 and has come-off from there to current levels of 950 (up 4.6 per cent). The drug ...
 Business Line1 month ago Glenmark Pharma climbs nearly 7% on smart Q3 earnings  DNA1 month ago Glenmark Pharmaceuticals Q3 results on Feb 02, 2017  Money Control2 months ago

Glenmark rises 7% on strong Q3 nos; US formulation sales up 102%

The company has registered 102 percent rise in its US formulation sales at Rs 1,231 crore, while India formulation sales was up 5.9 percent at Rs 516.8 crore.
 Money Control1 month ago Glenmark Pharma Q3 PAT seen up 37% to Rs 310 cr: HDFC Securities  Money Control2 months ago Glenmark Q3 PAT seen up 62.6% to Rs 363.5 cr: ICICI Securities  Money Control2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less